ICU Medical Reports Q3 Revenue of $560.4 Million, Reaffirms 2026 Guidance
ICU Medical reported Q3 2026 revenue of $560.4 million, up from $537.0 million a year earlier. Net income was $26.8 million versus a year-ago loss, and adjusted diluted EPS rose to $2.44 from $2.03.
Story updates
09:43:39 PM UTC
SquawkNews
ICU Medical's third-quarter revenue rose year over year as growth in Consumables and Infusion Systems more than offset lower Vital Care sales. Earnings improved from a year-earlier loss, supported by higher gross margin, tariff refunds, price increases and lower net interest expense; an investment…
ICU Medical reported third-quarter 2026 revenue of $560.4 million, up from $537.0 million a year earlier, and net income of $26.8 million compared with a year-ago loss. Adjusted diluted earnings per share rose to $2.44 from $2.03. The company reaffirmed its 2026 guidance and said it expects results…